Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence

Joon Young Song; Hee Jin Cheong; In Sook Hwang; Won Suk Choi; Yu Mi Jo; Dae Won Park; Geum Joo Cho; Taik Gun Hwang; Woo Joo Kim

doi:10.1016/j.vaccine.2010.03.067

Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence

Joon Young Song, Hee Jin Cheong, In Sook Hwang, Won Suk Choi, Yu Mi Jo, Dae Won Park, Geum Joo Cho, Taik Gun Hwang, Woo Joo Kim

Research output: Contribution to journal › Article › peer-review

105 Citations (Scopus)

Abstract

The elderly have been considered as the priority group for influenza vaccination, but their influenza vaccine-induced antibody was believed to decline more rapidly. Long-term immunogenicity of the influenza vaccine among the elderly was evaluated as compared to young adults. Serum hemagglutinin inhibition (HI) titers were determined at pre- and post-vaccination periods (at 1, 6, and 12 months after vaccination). Of the 1018 subjects, 716 (70.3%) were followed up during a 12-month period. Seroprotection rates at 1 month post-vaccination ranged from 70.1% to 90.3% depending on the age group and influenza vaccine virus strain. At 6 months post-vaccination, seroprotection rates for all three strains had declined significantly in adults ≥65 years (P < 0.01), but still met the EMEA criteria. Low pre-vaccination HI titer (<1:40) and advanced age were associated with early decline of HI titers, falling below seroprotective levels around 6 months after vaccination.

Original language	English
Pages (from-to)	3929-3935
Number of pages	7
Journal	Vaccine
Volume	28
Issue number	23
DOIs	https://doi.org/10.1016/j.vaccine.2010.03.067
Publication status	Published - 2010 May 21

Keywords

Elderly
Immunogenicity
Influenza
Vaccination

ASJC Scopus subject areas

Molecular Medicine
Immunology and Microbiology(all)
veterinary(all)
Public Health, Environmental and Occupational Health
Infectious Diseases

Access to Document

10.1016/j.vaccine.2010.03.067

Fingerprint Dive into the research topics of 'Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence'. Together they form a unique fingerprint.

Cite this

Long-term immunogenicity of influenza vaccine among the elderly : Risk factors for poor immune response and persistence. / Song, Joon Young; Cheong, Hee Jin; Hwang, In Sook; Choi, Won Suk; Jo, Yu Mi; Park, Dae Won; Cho, Geum Joo; Hwang, Taik Gun; Kim, Woo Joo.

In: Vaccine, Vol. 28, No. 23, 21.05.2010, p. 3929-3935.

Research output: Contribution to journal › Article › peer-review

@article{304b93ffc84748b8895fc0f137d1acef,

title = "Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence",

abstract = "The elderly have been considered as the priority group for influenza vaccination, but their influenza vaccine-induced antibody was believed to decline more rapidly. Long-term immunogenicity of the influenza vaccine among the elderly was evaluated as compared to young adults. Serum hemagglutinin inhibition (HI) titers were determined at pre- and post-vaccination periods (at 1, 6, and 12 months after vaccination). Of the 1018 subjects, 716 (70.3%) were followed up during a 12-month period. Seroprotection rates at 1 month post-vaccination ranged from 70.1% to 90.3% depending on the age group and influenza vaccine virus strain. At 6 months post-vaccination, seroprotection rates for all three strains had declined significantly in adults ≥65 years (P < 0.01), but still met the EMEA criteria. Low pre-vaccination HI titer (<1:40) and advanced age were associated with early decline of HI titers, falling below seroprotective levels around 6 months after vaccination.",

keywords = "Elderly, Immunogenicity, Influenza, Vaccination",

author = "Song, {Joon Young} and Cheong, {Hee Jin} and Hwang, {In Sook} and Choi, {Won Suk} and Jo, {Yu Mi} and Park, {Dae Won} and Cho, {Geum Joo} and Hwang, {Taik Gun} and Kim, {Woo Joo}",

year = "2010",

month = may,

day = "21",

doi = "10.1016/j.vaccine.2010.03.067",

language = "English",

volume = "28",

pages = "3929--3935",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier BV",

number = "23",

}

TY - JOUR

T1 - Long-term immunogenicity of influenza vaccine among the elderly

T2 - Risk factors for poor immune response and persistence

AU - Song, Joon Young

AU - Cheong, Hee Jin

AU - Hwang, In Sook

AU - Choi, Won Suk

AU - Jo, Yu Mi

AU - Park, Dae Won

AU - Cho, Geum Joo

AU - Hwang, Taik Gun

AU - Kim, Woo Joo

PY - 2010/5/21

Y1 - 2010/5/21

N2 - The elderly have been considered as the priority group for influenza vaccination, but their influenza vaccine-induced antibody was believed to decline more rapidly. Long-term immunogenicity of the influenza vaccine among the elderly was evaluated as compared to young adults. Serum hemagglutinin inhibition (HI) titers were determined at pre- and post-vaccination periods (at 1, 6, and 12 months after vaccination). Of the 1018 subjects, 716 (70.3%) were followed up during a 12-month period. Seroprotection rates at 1 month post-vaccination ranged from 70.1% to 90.3% depending on the age group and influenza vaccine virus strain. At 6 months post-vaccination, seroprotection rates for all three strains had declined significantly in adults ≥65 years (P < 0.01), but still met the EMEA criteria. Low pre-vaccination HI titer (<1:40) and advanced age were associated with early decline of HI titers, falling below seroprotective levels around 6 months after vaccination.

AB - The elderly have been considered as the priority group for influenza vaccination, but their influenza vaccine-induced antibody was believed to decline more rapidly. Long-term immunogenicity of the influenza vaccine among the elderly was evaluated as compared to young adults. Serum hemagglutinin inhibition (HI) titers were determined at pre- and post-vaccination periods (at 1, 6, and 12 months after vaccination). Of the 1018 subjects, 716 (70.3%) were followed up during a 12-month period. Seroprotection rates at 1 month post-vaccination ranged from 70.1% to 90.3% depending on the age group and influenza vaccine virus strain. At 6 months post-vaccination, seroprotection rates for all three strains had declined significantly in adults ≥65 years (P < 0.01), but still met the EMEA criteria. Low pre-vaccination HI titer (<1:40) and advanced age were associated with early decline of HI titers, falling below seroprotective levels around 6 months after vaccination.

KW - Elderly

KW - Immunogenicity

KW - Influenza

KW - Vaccination

UR - http://www.scopus.com/inward/record.url?scp=77952430761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952430761&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2010.03.067

DO - 10.1016/j.vaccine.2010.03.067

M3 - Article

C2 - 20394719

AN - SCOPUS:77952430761

VL - 28

SP - 3929

EP - 3935

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 23

ER -